Anacor Pharmaceuticals Inc., a Palo Alto, Calif.-based developer of topical therapeuticals, has filed for a $57.5 million IPO. It plans to trade on the Nasdaq under ticker symbol ANAC, with Morgan Stanley and Cowen & Co. serving as co-lead underwriters. VC backers include Rho Ventures, Venrock, Red Abbey Venture Partners and Aberdare Ventures. www.anacor.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.